| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/28/2010 | EP2209495A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 07/28/2010 | EP2209491A2 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6) |
| 07/28/2010 | EP2209489A1 Live attenuated mycoplasma strains |
| 07/28/2010 | EP1891210B1 Dengue serotype 2 attenuated strain |
| 07/28/2010 | EP1776387B1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 07/28/2010 | EP1667711B1 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 07/28/2010 | EP1545560B1 Compositions for inhibiting protein kinase c alpha for the treatment of diabetes mellitus |
| 07/28/2010 | EP1487856B1 Human antibodies specific to kdr and uses thereof |
| 07/28/2010 | EP1397486B1 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 07/28/2010 | EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/28/2010 | CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 07/28/2010 | CN1625409B Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 07/28/2010 | CN101790540A Local administration of chicken yolk immune globulins (igy) to treat and prevent fungal infections |
| 07/28/2010 | CN101790384A The use of monomycolyl glycerol (mmg) as an adjuvant |
| 07/28/2010 | CN101790383A Production of an homogeneous vaccine preparation for cancer treatment |
| 07/28/2010 | CN101790382A idiotypic vaccine |
| 07/28/2010 | CN101790381A Method for producing viral vaccines |
| 07/28/2010 | CN101790380A Conjugates of synthetic tlr agonists and uses therefor |
| 07/28/2010 | CN101790379A Multi-day delivery of biologically active substances |
| 07/28/2010 | CN101790378A Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase |
| 07/28/2010 | CN101790377A Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 07/28/2010 | CN101787371A Chemosynthetic HSV2 virus gD glycoprotein extracellular region gene segment as well as expression and application thereof |
| 07/28/2010 | CN101785857A Novel pneumococcal conjugate vaccine and preparation method thereof |
| 07/28/2010 | CN101785855A Botulinum toxin formulations for oral administration |
| 07/28/2010 | CN101016547B Method of preparing ocean double RNA virus MABV recombination albumen and application thereof |
| 07/27/2010 | US7763721 polynucleotides that code for immunoglobulin (IgE) binding immunogenic proteins, used in test kit for screening patients for allergies to food nuts |
| 07/27/2010 | US7763709 purified immunoglobulin (IgE) binding immunogenic proteins, used in test kit for screening patients for allergies to food nuts |
| 07/27/2010 | US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 07/27/2010 | US7763589 Administering a vector construct that expresses an immunogenic portion of an antigen derived from a pathogen, and administering an immunogenic protein of said antigen, to generate an immune response |
| 07/27/2010 | US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/27/2010 | US7763461 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferase |
| 07/27/2010 | US7763451 Culturing, nucleotide sequence encoding antigen at pH 7 to 8, adjusting amino acid sequence by deletion and replacement of peptide in the sequence, producing antibodies in vivo, vaccination, nucleic acid construct, transgenic cells |
| 07/27/2010 | US7763450 Functional influenza virus-like particles (VLPs) |
| 07/27/2010 | US7763420 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 07/27/2010 | US7763290 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/27/2010 | US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria |
| 07/27/2010 | US7763261 Anti-human cytomegalovirus antibodies |
| 07/27/2010 | US7763260 Murine calicivirus |
| 07/27/2010 | US7763259 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
| 07/27/2010 | US7763258 Used to assess protein binding interactions |
| 07/27/2010 | US7763257 Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
| 07/27/2010 | US7763254 Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions |
| 07/27/2010 | US7763253 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 07/27/2010 | US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 07/27/2010 | US7763251 Kits to assess the risk of tumor progression |
| 07/27/2010 | US7763250 Antibodies directed against amyloid-beta peptide and nucleic acids encoding same |
| 07/27/2010 | US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 07/27/2010 | US7763248 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763247 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763246 Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor |
| 07/27/2010 | US7763245 antibodies that specifically binds ubiquitin comprising a lysine linkage between a lysine residue of one ubiquitin molecule and the C-terminal glycine residue of another ubiquitin molecule |
| 07/27/2010 | US7763244 Immunoglobulins; competitive binding; gene expression inhibition; for prevention and treatment of gastrointestinal tract cancers, inflammatory bowel disorders, and diabetes |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
| 07/27/2010 | CA2339870C Antithrombin nucleotides and proteins from horn fly |
| 07/27/2010 | CA2332829C Vaccine delivery system |
| 07/27/2010 | CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/27/2010 | CA2264810C Method of producing active immunity with vaccine conjugate |
| 07/27/2010 | CA2263152C Immunologically active proteins from borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
| 07/27/2010 | CA2223300C Expression of lipoproteins |
| 07/22/2010 | WO2010083477A2 Broad spectrum vaccine against non-typhoidal salmonella |
| 07/22/2010 | WO2010083365A1 Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody |
| 07/22/2010 | WO2010083163A1 The role of p110 delta signaling in morbidity and lung pathology induced by influenza virus infection |
| 07/22/2010 | WO2010083111A1 Purified plasmodium and vaccine compositions |
| 07/22/2010 | WO2010082136A1 Recombinant monovalent antibodies |
| 07/22/2010 | WO2010082134A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 07/22/2010 | WO2010082020A1 Vaccine |
| 07/22/2010 | WO2010081890A1 Anti-kir3d antibodies |
| 07/22/2010 | WO2010081875A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | WO2010081787A1 IMPROVED TNFα ANTAGONISM, PROPHYLAXIS & THERAPY WITH REDUCED ORGAN NECROSIS |
| 07/22/2010 | WO2010081766A1 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| 07/22/2010 | WO2010081738A1 Vaccine compositions |
| 07/22/2010 | WO2010081257A1 Composition comprising bacillus calmette guerin polysaccharides and bacillus calmette guerin nucleic acids and use of preparing medicament thereof |
| 07/22/2010 | WO2010060430A3 Optimized influenza vaccines |
| 07/22/2010 | WO2010057882A3 Composition for producing anti-amyloid beta peptide antibodies with d-peptides |
| 07/22/2010 | WO2010056948A3 Humanized anti-il-6 antibodies |
| 07/22/2010 | WO2010052214A3 Novel method |
| 07/22/2010 | WO2010051502A3 Light targeting molecules and uses thereof |
| 07/22/2010 | WO2010045506A3 Sustained drug delivery system |
| 07/22/2010 | WO2010044889A3 Torque teno virus (ttv) isolates and compositions |
| 07/22/2010 | WO2010037095A3 Agents and methods for the treatment of cancer |
| 07/22/2010 | WO2010034015A3 Modulating the alternative complement pathway |
| 07/22/2010 | WO2010033923A3 Genus-wide chlamydial peptide vaccine antigens |
| 07/22/2010 | WO2010027370A9 Compositions and methods for the treatment of solid tumor cancers |
| 07/22/2010 | WO2010024897A3 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer |
| 07/22/2010 | WO2010018378A3 Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy |
| 07/22/2010 | WO2010009277A3 Immunogenic amphipathic peptide compositions |
| 07/22/2010 | WO2010003225A8 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 07/22/2010 | WO2009158682A3 Compositions and methods for diagnosing and treating pathogenic disorders |
| 07/22/2010 | US20100186102 Methods and compositions for post-transcriptional gene silencing |
| 07/22/2010 | US20100186100 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 07/22/2010 | US20100184951 Truncated BAFF Receptors |
| 07/22/2010 | US20100184682 Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses |
| 07/22/2010 | US20100184639 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 07/22/2010 | US20100184638 Galanin Receptors and Brain Injury |
| 07/22/2010 | US20100184139 BASB082 polynucleotides |
| 07/22/2010 | US20100184091 Method for determining MIF content |
| 07/22/2010 | US20100184084 Methods for measuring platelet reactivity of individuals treated with drug eluting stents |
| 07/22/2010 | US20100184014 Non-M, non-O HIV-1 strains, fragments and uses |